We help Oxford ideas come to life

Oxford University Innovation is a wholly-owned subsidiary of the University of Oxford. We manage the University’s technology transfer and consulting activities.

For details of OUI's response to the Coronavirus (COVID-19), including expedited access to Oxford IP, please read more here.

To learn more about Oxford's Coronavirus research see here.

Launch innovative ideas

Find out more  >

Invest in new ventures

Find out more  >

Provide or access consulting services

Find out more  >

Latest News

Oxford University Innovation Q1 2021 Update News from OUI Oxford University Innovation Q1 2021 Update News from OUI Singula Bio provides new hope for cancer with diverse, individualised therapies Developing neoantigen-based individualised cell therapies. Singula Bio provides new hope for cancer with diverse, individualised therapies Developing neoantigen-based individualised cell therapies. Cancer vaccines are goal of new Oxford University company OxVax has been created to produce vaccines for cancer. Cancer vaccines are goal of new Oxford University company OxVax has been created to produce vaccines for cancer.

Innovation Highlights

Investment Opportunities Tax-efficient investment in Oxford spinouts Investment Opportunities Tax-efficient investment in Oxford spinouts Access to expertise Academic consultancy from Consulting Services Access to expertise Academic consultancy from Consulting Services Our Technologies Licensing opportunities, searchable Our Technologies Licensing opportunities, searchable Your privacy Our privacy policy, also available from the footer of every page Your privacy Our privacy policy, also available from the footer of every page

Ready to get in touch?

Contact Us
© Oxford University Innovation